Liquidia's EBIT per Share for the
three
months ended in Mar. 2024 was $-0.51.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 was $-1.45.
During the past 3 years, the average EBIT per Share Growth Rate was 13.50% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 29.80% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Liquidia's EBIT per Share or its related term are showing as below:
LQDA'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: 6.7 Med: 18.9 Max: 48.1
Current: 13.5
During the past 8 years, the highest 3-Year average EBIT per Share Growth Rate of Liquidia was 48.10% per year. The lowest was 6.70% per year. And the median was 18.90% per year.
LQDA's 3-Year EBIT Growth Rate is ranked better than 62.93% of 1311
companies
in the Biotechnology industry
Industry Median: 3.7
vs LQDA: 13.50
Liquidia's EBIT for the
three
months ended in Mar. 2024 was $-38.40 Mil.
Liquidia EBIT per Share Historical Data
The historical data trend for Liquidia's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.45
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Liquidia (NAS:LQDA) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Liquidia EBIT per Share Related Terms
Thank you for viewing the detailed overview of Liquidia's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH). It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles designed to improve the safety, efficacy, and performance of a wide range of therapies. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
LQDA has been successfully added to your 